Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Recruiting 3Terminated 1Not yet recruiting 1Enrolling by invitation 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3Gynecologic 2Breast 2Sarcoma 1Gastrointestinal 1Dermatologic 1

Conditions

Prostatic Neoplasms 3Ovarian Neoplasms 2Neoplastic Syndromes, Hereditary 2Breast Neoplasms 2Triple Negative Breast Neoplasms 1Sarcoma 1Pancreatic Neoplasms 1Multiple Myeloma 1Melanoma 1Lymphoproliferative Disorders 1Kidney Neoplasms 1Hereditary Breast and Ovarian Cancer Syndrome 1Hematologic Neoplasms 1Cytopenia 1Congenital Bone Marrow Failure Syndromes 1Colorectal Neoplasms, Hereditary Nonpolyposis 1Colorectal Neoplasms 1Carcinoma, Intraductal, Noninfiltrating 1Breast Neoplasms, Male 1Bone Marrow Failure Disorders 1

Interventions

Magnetic Resonance Spectroscopy 51Specimen Handling 42enzalutamide 36Androgen Antagonists 35Radiosurgery 33Radiotherapy 31darolutamide 26Prednisone 26Abiraterone Acetate 25Leuprolide 22Docetaxel 22apalutamide 21abiraterone 19Pluvicto 19Standard of Care 18Triptorelin Pamoate 17Radiation 17Biopsy 16relugolix 15acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 15Goserelin 14Blood Specimen Collection 13gallium 68 PSMA-11 12X-Rays 11Surveys and Questionnaires 11pembrolizumab 10luprolide acetate gel depot 10Carboplatin 10Methods 9Interviews as Topic 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × Prostatic Neoplasms × Genetic Counseling × Clear all
NCT05225428 2026-05-22

VERDI

Dana-Farber Cancer Institute

Phase NA Recruiting
1,020 enrolled
BreastDermatologicGastrointestinalGenitourinaryGynecologicSarcoma

Breast Neoplasms, Kidney Neoplasms, Melanoma, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma, Colorectal Neoplasms

NCT05487846 2026-04-14

Peer Navigation for the Support of Metastatic Prostate Cancer Patients Undergoing Genetic Evaluation

Thomas Jefferson University

Phase NA Recruiting
120 enrolled
Genitourinary

Prostatic Neoplasms

NCT06422455 2026-03-18

Access to Genetic Testing in Underserved Patients With Cancer

University of Southern California

Phase NA Recruiting
800 enrolled
BreastGenitourinaryGynecologic

Breast Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Breast Neoplasms, Male, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡